Harshbarger, Diana
☆Alerts · when they speak
Get an alert the moment Harshbarger, Diana speaks on the record.
Start free →
75%
spoke · 3 of 4 transcribed hearings
5min
speaking time on the record
27
speaking turns
1,045
words on the record
Talks about
okay
On the record
Rep. Harshbarger's own words —
✓ VALIDATED
Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.
Jul 15, 2026
73:52
Harshbarger, Diana. Yeah, absolutely. I agree with everything. One point that stood out in your testimony, sir, was the limited number of FDA inspections conducted in China, and I have 11 seconds left. But if FDA cannot routinely inspect foreign trial sites, how confident should Americans be in relying heavily on that ...
Committee activity
10 recent
HSE
Full Committee Markup of Twenty-Nine Pieces of Legislation
HSE
● SPOKEMaintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.
HSE
Three Pieces of Legislation
HSE
Subcommittee Markup of Six Pieces of Legislation
HSE
Nine Pieces of Legislation
HSE
● SPOKEState Medicaid Program Integrity: Examining Fraud Risks and Oversight Deficiencies.
HSE
Markup of Fifteen Bills
HSE
Subcommittee Markup of Eight Pieces of Legislation
HSE
"Lowering Health Care Costs for All Americans: Examining Policies to Increase Health Care Transparency."
HSE
● SPOKENuclear Permitting Reform: Legislation to Advance Efficient Licensing